Listed

Revolution Medicines, Inc.

RVMDNasdaqCIK 1628171HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$0, Q4 FY2024
Operating income−$505.1m, Q2 FY2026
Net income−$644.4m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m0.0Revenue, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-06, accession 0000950170-24-122303.Report this figure0.7Revenue, Q4 FY2023, three months to 2023-12-31$742.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001193125-26-071563. Derived: 12-month figure less the 9-month figure.Report this figure0.0Revenue, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-05-08, accession 0000950170-24-055655.Report this figure0.0Revenue, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-08-07, accession 0000950170-24-092783.Report this figure0.0Revenue, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-06, accession 0000950170-24-122303.Report this figure0.0Revenue, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001193125-26-071563. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reported
Research and development$m108Research and development, Q3 FY2023, three months to 2023-09-30$107.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-06, accession 0000950170-24-122303.Report this figure148Research and development, Q4 FY2023, three months to 2023-12-31$148.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-25, accession 0001193125-26-071563. Derived: 12-month figure less the 9-month figure.Report this figure118Research and development, Q1 FY2024, three months to 2024-03-31$118.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-07, accession 0000950170-25-065660.Report this figure135Research and development, Q2 FY2024, three months to 2024-06-30$134.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-06, accession 0000950170-25-104022.Report this figure152Research and development, Q3 FY2024, three months to 2024-09-30$151.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-05, accession 0001193125-25-266923.Report this figure188Research and development, Q4 FY2024, three months to 2024-12-31$188.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-25, accession 0001193125-26-071563. Derived: 12-month figure less the 9-month figure.Report this figure206Research and development, Q1 FY2025, three months to 2025-03-31$205.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-06, accession 0001193125-26-208969.Report this figure224Research and development, Q2 FY2025, three months to 2025-06-30$224.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-05, accession 0001193125-26-335104.Report this figure263Research and development, Q3 FY2025, three months to 2025-09-30$262.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-05, accession 0001193125-25-266923.Report this figure295Research and development, Q4 FY2025, three months to 2025-12-31$294.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-25, accession 0001193125-26-071563. Derived: 12-month figure less the 9-month figure.Report this figure344Research and development, Q1 FY2026, three months to 2026-03-31$344.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-06, accession 0001193125-26-208969.Report this figure395Research and development, Q2 FY2026, three months to 2026-06-30$394.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-05, accession 0001193125-26-335104.Report this figure
Operating income$m(123)Operating income, Q3 FY2023, three months to 2023-09-30−$123.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-06, accession 0000950170-24-122303.Report this figure(180)Operating income, Q4 FY2023, three months to 2023-12-31−$180.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-25, accession 0001193125-26-071563. Derived: 12-month figure less the 9-month figure.Report this figure(141)Operating income, Q1 FY2024, three months to 2024-03-31−$140.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-07, accession 0000950170-25-065660.Report this figure(157)Operating income, Q2 FY2024, three months to 2024-06-30−$156.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-06, accession 0000950170-25-104022.Report this figure(176)Operating income, Q3 FY2024, three months to 2024-09-30−$175.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-266923.Report this figure(216)Operating income, Q4 FY2024, three months to 2024-12-31−$216.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-25, accession 0001193125-26-071563. Derived: 12-month figure less the 9-month figure.Report this figure(241)Operating income, Q1 FY2025, three months to 2025-03-31−$240.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-06, accession 0001193125-26-208969.Report this figure(265)Operating income, Q2 FY2025, three months to 2025-06-30−$264.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-335104.Report this figure(315)Operating income, Q3 FY2025, three months to 2025-09-30−$315.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-266923.Report this figure(362)Operating income, Q4 FY2025, three months to 2025-12-31−$361.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-25, accession 0001193125-26-071563. Derived: 12-month figure less the 9-month figure.Report this figure(445)Operating income, Q1 FY2026, three months to 2026-03-31−$445.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-06, accession 0001193125-26-208969.Report this figure(505)Operating income, Q2 FY2026, three months to 2026-06-30−$505.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-335104.Report this figure
Interest expense$mnot reportednot reportednot reportednot reported0.0Interest expense, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-05, accession 0001193125-25-266923.Report this figure0.0Interest expense, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-25, accession 0001193125-26-071563. Derived: 12-month figure less the 9-month figure.Report this figure0.0Interest expense, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-06, accession 0001193125-26-208969.Report this figure0.9Interest expense, Q2 FY2025, three months to 2025-06-30$867.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-05, accession 0001193125-26-335104.Report this figure11.4Interest expense, Q3 FY2025, three months to 2025-09-30$11.4m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-05, accession 0001193125-25-266923.Report this figure11.9Interest expense, Q4 FY2025, three months to 2025-12-31$11.9m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-25, accession 0001193125-26-071563. Derived: 12-month figure less the 9-month figure.Report this figure12.2Interest expense, Q1 FY2026, three months to 2026-03-31$12.2m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-06, accession 0001193125-26-208969.Report this figure23.8Interest expense, Q2 FY2026, three months to 2026-06-30$23.8m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-05, accession 0001193125-26-335104.Report this figure
Income tax$m(3.9)Income tax, Q3 FY2023, three months to 2023-09-30−$3.9m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-06, accession 0000950170-24-122303.Report this figure0.3Income tax, Q4 FY2023, three months to 2023-12-31$343.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-25, accession 0001193125-26-071563. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-05-08, accession 0000950170-24-055655.Report this figure0.0Income tax, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-08-07, accession 0000950170-24-092783.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-06, accession 0000950170-24-122303.Report this figure(0.8)Income tax, Q4 FY2024, three months to 2024-12-31−$753.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-25, accession 0001193125-26-071563. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reported
Net income$m(108)Net income, Q3 FY2023, three months to 2023-09-30−$108.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-06, accession 0000950170-24-122303.Report this figure(162)Net income, Q4 FY2023, three months to 2023-12-31−$161.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-25, accession 0001193125-26-071563. Derived: 12-month figure less the 9-month figure.Report this figure(116)Net income, Q1 FY2024, three months to 2024-03-31−$116.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-266923.Report this figure(133)Net income, Q2 FY2024, three months to 2024-06-30−$133.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-266923.Report this figure(156)Net income, Q3 FY2024, three months to 2024-09-30−$156.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-266923.Report this figure(195)Net income, Q4 FY2024, three months to 2024-12-31−$194.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-25, accession 0001193125-26-071563. Derived: 12-month figure less the 9-month figure.Report this figure(213)Net income, Q1 FY2025, three months to 2025-03-31−$213.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-335104.Report this figure(248)Net income, Q2 FY2025, three months to 2025-06-30−$247.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-335104.Report this figure(305)Net income, Q3 FY2025, three months to 2025-09-30−$305.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-266923.Report this figure(365)Net income, Q4 FY2025, three months to 2025-12-31−$364.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-25, accession 0001193125-26-071563. Derived: 12-month figure less the 9-month figure.Report this figure(454)Net income, Q1 FY2026, three months to 2026-03-31−$453.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-335104.Report this figure(644)Net income, Q2 FY2026, three months to 2026-06-30−$644.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-335104.Report this figure
Diluted EPS$ per share(0.99)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.99 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-06, accession 0000950170-24-122303.Report this figurenot reported(0.70)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.70 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-07, accession 0000950170-25-065660.Report this figure(0.81)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.81 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-06, accession 0000950170-25-104022.Report this figure(0.94)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.94 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-05, accession 0001193125-25-266923.Report this figurenot reported(1.13)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$1.13 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-06, accession 0001193125-26-208969.Report this figure(1.31)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$1.31 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001193125-26-335104.Report this figure(1.61)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$1.61 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-05, accession 0001193125-25-266923.Report this figurenot reported(2.29)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$2.29 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-06, accession 0001193125-26-208969.Report this figure(3.06)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$3.06 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001193125-26-335104.Report this figure
Basic EPS$ per share(0.99)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.99 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-06, accession 0000950170-24-122303.Report this figurenot reported(0.70)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.70 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-07, accession 0000950170-25-065660.Report this figure(0.81)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.81 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-06, accession 0000950170-25-104022.Report this figure(0.94)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.94 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-05, accession 0001193125-25-266923.Report this figurenot reported(1.13)Basic EPS, Q1 FY2025, three months to 2025-03-31−$1.13 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-06, accession 0001193125-26-208969.Report this figure(1.31)Basic EPS, Q2 FY2025, three months to 2025-06-30−$1.31 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-05, accession 0001193125-26-335104.Report this figure(1.61)Basic EPS, Q3 FY2025, three months to 2025-09-30−$1.61 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-05, accession 0001193125-25-266923.Report this figurenot reported(2.29)Basic EPS, Q1 FY2026, three months to 2026-03-31−$2.29 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-06, accession 0001193125-26-208969.Report this figure(3.06)Basic EPS, Q2 FY2026, three months to 2026-06-30−$3.06 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-05, accession 0001193125-26-335104.Report this figure

Balance sheet

Cash and equivalents$815.4m, Q2 FY2026
Shareholders' equity$2.61bn, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m358Cash and equivalents, Q3 FY2023, at 2023-09-30$358.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-06, accession 0000950170-24-122303.Report this figure696Cash and equivalents, FY2023, at 2023-12-31$696.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-25, accession 0001193125-26-071563.Report this figure288Cash and equivalents, Q1 FY2024, at 2024-03-31$288.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-07, accession 0000950170-25-065660.Report this figure276Cash and equivalents, Q2 FY2024, at 2024-06-30$275.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-06, accession 0000950170-25-104022.Report this figure201Cash and equivalents, Q3 FY2024, at 2024-09-30$201.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-05, accession 0001193125-25-266923.Report this figure543Cash and equivalents, FY2024, at 2024-12-31$543.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-25, accession 0001193125-26-071563.Report this figure334Cash and equivalents, Q1 FY2025, at 2025-03-31$333.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-06, accession 0001193125-26-208969.Report this figure402Cash and equivalents, Q2 FY2025, at 2025-06-30$402.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001193125-26-335104.Report this figure217Cash and equivalents, Q3 FY2025, at 2025-09-30$217.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-05, accession 0001193125-25-266923.Report this figure384Cash and equivalents, FY2025, at 2025-12-31$383.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001193125-26-335104.Report this figure441Cash and equivalents, Q1 FY2026, at 2026-03-31$440.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-06, accession 0001193125-26-208969.Report this figure815Cash and equivalents, Q2 FY2026, at 2026-06-30$815.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001193125-26-335104.Report this figure
Current assets$m824Current assets, Q3 FY2023, at 2023-09-30$824.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-06, accession 0000950170-23-059391.Report this figure1,879Current assets, FY2023, at 2023-12-31$1.88bn. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-26, accession 0000950170-25-027736.Report this figure1,729Current assets, Q1 FY2024, at 2024-03-31$1.73bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-08, accession 0000950170-24-055655.Report this figure1,625Current assets, Q2 FY2024, at 2024-06-30$1.62bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-07, accession 0000950170-24-092783.Report this figure1,579Current assets, Q3 FY2024, at 2024-09-30$1.58bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-06, accession 0000950170-24-122303.Report this figure2,328Current assets, FY2024, at 2024-12-31$2.33bn. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-25, accession 0001193125-26-071563.Report this figure2,135Current assets, Q1 FY2025, at 2025-03-31$2.13bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-07, accession 0000950170-25-065660.Report this figure2,176Current assets, Q2 FY2025, at 2025-06-30$2.18bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-06, accession 0000950170-25-104022.Report this figure1,977Current assets, Q3 FY2025, at 2025-09-30$1.98bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-05, accession 0001193125-25-266923.Report this figure2,075Current assets, FY2025, at 2025-12-31$2.08bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-05, accession 0001193125-26-335104.Report this figure1,968Current assets, Q1 FY2026, at 2026-03-31$1.97bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-06, accession 0001193125-26-208969.Report this figure4,028Current assets, Q2 FY2026, at 2026-06-30$4.03bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-05, accession 0001193125-26-335104.Report this figure
Total assets$m984Total assets, Q3 FY2023, at 2023-09-30$984.2m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-06, accession 0000950170-23-059391.Report this figure2,062Total assets, FY2023, at 2023-12-31$2.06bn. XBRL concept us-gaap:Assets. 10-K filed 2025-02-26, accession 0000950170-25-027736.Report this figure1,908Total assets, Q1 FY2024, at 2024-03-31$1.91bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-08, accession 0000950170-24-055655.Report this figure1,808Total assets, Q2 FY2024, at 2024-06-30$1.81bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-07, accession 0000950170-24-092783.Report this figure1,763Total assets, Q3 FY2024, at 2024-09-30$1.76bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-06, accession 0000950170-24-122303.Report this figure2,558Total assets, FY2024, at 2024-12-31$2.56bn. XBRL concept us-gaap:Assets. 10-K filed 2026-02-25, accession 0001193125-26-071563.Report this figure2,365Total assets, Q1 FY2025, at 2025-03-31$2.37bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-07, accession 0000950170-25-065660.Report this figure2,430Total assets, Q2 FY2025, at 2025-06-30$2.43bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-06, accession 0000950170-25-104022.Report this figure2,252Total assets, Q3 FY2025, at 2025-09-30$2.25bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-05, accession 0001193125-25-266923.Report this figure2,355Total assets, FY2025, at 2025-12-31$2.35bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-05, accession 0001193125-26-335104.Report this figure2,254Total assets, Q1 FY2026, at 2026-03-31$2.25bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-06, accession 0001193125-26-208969.Report this figure4,323Total assets, Q2 FY2026, at 2026-06-30$4.32bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-05, accession 0001193125-26-335104.Report this figure
Current liabilities$m85.5Current liabilities, Q3 FY2023, at 2023-09-30$85.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-06, accession 0000950170-23-059391.Report this figure144Current liabilities, FY2023, at 2023-12-31$143.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-26, accession 0000950170-25-027736.Report this figure93.7Current liabilities, Q1 FY2024, at 2024-03-31$93.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-08, accession 0000950170-24-055655.Report this figure105Current liabilities, Q2 FY2024, at 2024-06-30$105.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-07, accession 0000950170-24-092783.Report this figure111Current liabilities, Q3 FY2024, at 2024-09-30$110.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-06, accession 0000950170-24-122303.Report this figure164Current liabilities, FY2024, at 2024-12-31$163.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-25, accession 0001193125-26-071563.Report this figure159Current liabilities, Q1 FY2025, at 2025-03-31$158.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-07, accession 0000950170-25-065660.Report this figure185Current liabilities, Q2 FY2025, at 2025-06-30$184.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-06, accession 0000950170-25-104022.Report this figure246Current liabilities, Q3 FY2025, at 2025-09-30$245.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-05, accession 0001193125-25-266923.Report this figure290Current liabilities, FY2025, at 2025-12-31$290.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-05, accession 0001193125-26-335104.Report this figure290Current liabilities, Q1 FY2026, at 2026-03-31$289.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-06, accession 0001193125-26-208969.Report this figure354Current liabilities, Q2 FY2026, at 2026-06-30$354.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-05, accession 0001193125-26-335104.Report this figure
Total liabilities$m147Total liabilities, Q3 FY2023, at 2023-09-30$146.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-06, accession 0000950170-23-059391.Report this figure236Total liabilities, FY2023, at 2023-12-31$235.5m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-26, accession 0000950170-25-027736.Report this figure183Total liabilities, Q1 FY2024, at 2024-03-31$182.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-08, accession 0000950170-24-055655.Report this figure190Total liabilities, Q2 FY2024, at 2024-06-30$189.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-07, accession 0000950170-24-092783.Report this figure197Total liabilities, Q3 FY2024, at 2024-09-30$196.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-06, accession 0000950170-24-122303.Report this figure293Total liabilities, FY2024, at 2024-12-31$293.1m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-25, accession 0001193125-26-071563.Report this figure287Total liabilities, Q1 FY2025, at 2025-03-31$287.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-07, accession 0000950170-25-065660.Report this figure564Total liabilities, Q2 FY2025, at 2025-06-30$564.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-06, accession 0000950170-25-104022.Report this figure655Total liabilities, Q3 FY2025, at 2025-09-30$655.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-05, accession 0001193125-25-266923.Report this figure723Total liabilities, FY2025, at 2025-12-31$723.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-05, accession 0001193125-26-335104.Report this figure754Total liabilities, Q1 FY2026, at 2026-03-31$753.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-06, accession 0001193125-26-208969.Report this figure1,717Total liabilities, Q2 FY2026, at 2026-06-30$1.72bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-05, accession 0001193125-26-335104.Report this figure
Shareholders' equity$m837Shareholders' equity, Q3 FY2023, at 2023-09-30$837.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-06, accession 0000950170-24-122303.Report this figure1,826Shareholders' equity, FY2023, at 2023-12-31$1.83bn. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-25, accession 0001193125-26-071563.Report this figure1,725Shareholders' equity, Q1 FY2024, at 2024-03-31$1.73bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001193125-25-266923.Report this figure1,619Shareholders' equity, Q2 FY2024, at 2024-06-30$1.62bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001193125-25-266923.Report this figure1,566Shareholders' equity, Q3 FY2024, at 2024-09-30$1.57bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001193125-25-266923.Report this figure2,265Shareholders' equity, FY2024, at 2024-12-31$2.27bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-335104.Report this figure2,078Shareholders' equity, Q1 FY2025, at 2025-03-31$2.08bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-335104.Report this figure1,865Shareholders' equity, Q2 FY2025, at 2025-06-30$1.87bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-335104.Report this figure1,597Shareholders' equity, Q3 FY2025, at 2025-09-30$1.60bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001193125-25-266923.Report this figure1,631Shareholders' equity, FY2025, at 2025-12-31$1.63bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-335104.Report this figure1,500Shareholders' equity, Q1 FY2026, at 2026-03-31$1.50bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-335104.Report this figure2,606Shareholders' equity, Q2 FY2026, at 2026-06-30$2.61bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-335104.Report this figure

Cash flow

Operating cash flow−$387.3m, Q2 FY2026
Capital expenditure$2.3m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(100)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$100.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-06, accession 0000950170-24-122303. Derived: 9-month figure less the 6-month figure.Report this figure(121)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$120.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-25, accession 0001193125-26-071563. Derived: 12-month figure less the 9-month figure.Report this figure(161)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$160.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-07, accession 0000950170-25-065660.Report this figure(128)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$128.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-06, accession 0000950170-25-104022. Derived: 6-month figure less the 3-month figure.Report this figure(130)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$130.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-05, accession 0001193125-25-266923. Derived: 9-month figure less the 6-month figure.Report this figure(138)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$138.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-25, accession 0001193125-26-071563. Derived: 12-month figure less the 9-month figure.Report this figure(194)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$194.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0001193125-26-208969.Report this figure(222)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$221.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001193125-26-335104. Derived: 6-month figure less the 3-month figure.Report this figure(207)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$207.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-05, accession 0001193125-25-266923. Derived: 9-month figure less the 6-month figure.Report this figure(274)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$274.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-25, accession 0001193125-26-071563. Derived: 12-month figure less the 9-month figure.Report this figure(354)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$354.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0001193125-26-208969.Report this figure(387)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$387.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001193125-26-335104. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m2.5Capital expenditure, Q3 FY2023, three months to 2023-09-30$2.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-06, accession 0000950170-24-122303. Derived: 9-month figure less the 6-month figure.Report this figure2.3Capital expenditure, Q4 FY2023, three months to 2023-12-31$2.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-25, accession 0001193125-26-071563. Derived: 12-month figure less the 9-month figure.Report this figure3.2Capital expenditure, Q1 FY2024, three months to 2024-03-31$3.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-07, accession 0000950170-25-065660.Report this figure2.4Capital expenditure, Q2 FY2024, three months to 2024-06-30$2.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-06, accession 0000950170-25-104022. Derived: 6-month figure less the 3-month figure.Report this figure3.5Capital expenditure, Q3 FY2024, three months to 2024-09-30$3.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-05, accession 0001193125-25-266923. Derived: 9-month figure less the 6-month figure.Report this figure1.2Capital expenditure, Q4 FY2024, three months to 2024-12-31$1.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-25, accession 0001193125-26-071563. Derived: 12-month figure less the 9-month figure.Report this figure3.3Capital expenditure, Q1 FY2025, three months to 2025-03-31$3.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-06, accession 0001193125-26-208969.Report this figure7.5Capital expenditure, Q2 FY2025, three months to 2025-06-30$7.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-05, accession 0001193125-26-335104. Derived: 6-month figure less the 3-month figure.Report this figure3.3Capital expenditure, Q3 FY2025, three months to 2025-09-30$3.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-05, accession 0001193125-25-266923. Derived: 9-month figure less the 6-month figure.Report this figure1.9Capital expenditure, Q4 FY2025, three months to 2025-12-31$1.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-25, accession 0001193125-26-071563. Derived: 12-month figure less the 9-month figure.Report this figure1.5Capital expenditure, Q1 FY2026, three months to 2026-03-31$1.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-06, accession 0001193125-26-208969.Report this figure2.3Capital expenditure, Q2 FY2026, three months to 2026-06-30$2.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-05, accession 0001193125-26-335104. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)210.89m, Q2 FY2026
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q1 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares84.7Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3084,694,860 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-06, accession 0000950170-23-059391.Report this figure94.8Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3194,831,979 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-08, accession 0000950170-24-055655.Report this figure107Diluted shares (weighted), Q1 FY2023, three months to 2023-06-30106,884,185 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-07, accession 0000950170-24-092783.Report this figure109Diluted shares (weighted), Q3 FY2023, three months to 2023-09-30109,233,084 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-06, accession 0000950170-24-122303.Report this figure165Diluted shares (weighted), Q1 FY2024, three months to 2024-03-31164,729,200 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-07, accession 0000950170-25-065660.Report this figure165Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30165,141,936 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-06, accession 0000950170-25-104022.Report this figure167Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30166,843,984 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-05, accession 0001193125-25-266923.Report this figure188Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31188,145,904 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-06, accession 0001193125-26-208969.Report this figure189Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30188,583,288 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-05, accession 0001193125-26-335104.Report this figure189Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30189,231,562 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-05, accession 0001193125-25-266923.Report this figure198Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31198,098,047 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-06, accession 0001193125-26-208969.Report this figure211Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30210,893,604 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-05, accession 0001193125-26-335104.Report this figure

Shares outstanding: 214.34mShares outstanding, period not labelled, at 2026-07-31214,336,418 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-05, accession 0001193125-26-335104.Report this figure at Jul 31, 2026, from the cover of the 10-Q filed Aug 5, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:44 ET. Listed shows no prices and gives no investment advice.